Toggle navigation
Home
Search
Services
Blog
Contact
About
Randomized Evaluation of Vad Intervention Before Intropic Therapy (Revive-It) Pi
Aaronson, Keith
University of Michigan Ann Arbor, Ann Arbor, MI, United States
Search 13 grants from Keith Aaronson
Search grants from University of Michigan Ann Arbor
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biological Equivalence of In Vitro Plasmodium falciparum Culture for Practical Malaria Vaccine Development
Vector and Host Contributions to the Regulation of E. Chaffeensis Gene Expression
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)
Biomechanical understanding of accommodation mechanism with Brillouin microscopy
Transition Zone Dosimetry
Recently added grants:
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC
Planning and Evaluation
Developmental Funds
A technological approach for performance status assessment in advanced cancer patients
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
268201100026C-0-0-1
Application #
8351947
Study Section
Project Start
2011-01-15
Project End
2016-01-14
Budget Start
Budget End
Support Year
Fiscal Year
2011
Total Cost
$4,952,781
Indirect Cost
Institution
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Comments
Be the first to comment on Keith Aaronson's grant
